Summary
A case of acute parvovirus B19 infection causing fever, anaemia, leukopenia, and red cell aplasia, in a patient with chronic rheumatoid arthritis is described. The patient had received low doses of corticosteroids for several years, and a small dose of methotrexate recently. There was no evidence of haemolytic anaemia, iron deficiency or drug toxicity. Recovery was associated with the development of antibodies against parvovirus B19, and clearance of viraemia as detected by the polymerase chain reaction. Possible mechanisms for the development of leukopenia are discussed, but there was no evidence for haemophagocytosis.
Similar content being viewed by others
References
Cossart, Y.E., Field, A.M., Cant, B., Widdows, D. Parvovirus-like particles in human sera. Lancet 1975, i, 72–73.
Harris, J.W. Parvovirus B19 for the hematologist. Am J Hematol 1992, 39, 119–130.
Pattison, J.R., Jones, S.E., Hodgson, J., et al. Parvovirus infections and hypoplastic crisis in sickle-cell anemia. Lancet 1981, i, 664–665.
Anderson, M.J., Lewis, E., Kidd, I.M., Hall, S.M., Cohen, B.J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hygiene 1984, 93, 85–93.
De Mayolo, J.A., Temple, D.J. Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection. Southern Medical Journal 1990, 82, 1480–1481.
Frickhofen, N., Abkowitz, J.L., Safford, M., et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990, 113, 926–933.
Anderson, M.J., Higgins, P.J., Davis, L.R., et al. Experimental parvoviral infection in humans. J Infect Dis 1985, 152, 257–265.
Potter, C.G., Potter, A.C., Hutton, C.S.R. et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus B19. J Clin Invest 1987, 79, 1486–1492.
Muir, K., Todd, W.T.A., Watson, W.H., Fitzsimons, E. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet 1992, 339, 1139–1140.
Brown, C.S., van Brussel, M.J.A.M.W., Wassenaar, A.L.M., van Elsacker-Niele, A.-M.W., Weiland, H.T., Salimans, M.M.M. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen, J Virol Methods 1990, 29, 53–62.
Salimans, M.M.M. Detection of human parvovirus B19 DNA by dot-hybridisation and the polymerase chain reaction: applications for diagnosis of infections. Behring Inst Mitt 1990, 85, 39–45.
Bell, L.M., Naides, S.J., Stoffman, P., et al. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989, 321, 485–491.
Evans, J.P., Rossiter, M.A., Kumaran, T.O., et al. Human parvovirus aplasia: a case due to cross infection in a ward. Br Med J 1982, 288, 681.
Anonymous. Risks associated with human parvovirus B19 infection. MMWR 1989, 38, 81–97.
Young, N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988, 25, 159–172.
Ozawa, K., Ayub, J., Kajigaya, S., Shimada, T., Young, N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988, 62, 2884–2889.
Shimomura, S., Komatsu, N., Frickhofen, N., Anderson, S., Kajigaya, S., Young, N.S. First continuous propagation of B19 parvovirus in a cell line. Blood 1992, 79, 18–24.
Török, T.J. Parvovirus B19 and human disease. Adv Intern Med 1992, 37, 431–455.
Kurtzman, G.J., Gascon, P., Caras, M., et al. B19 parvovirus replicates in circulating cells of acutely infected patients. Blood 1988, 71, 1448–1454.
Weinblatt, M.E. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol 1985, 12 (suppl), 35–39.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamper, A.M., Malbrain, M., Zachee, P. et al. Parvovirus infection causing red cell aplasia and leukopenia in rheumatoid arthritis. Clin Rheumatol 13, 129–131 (1994). https://doi.org/10.1007/BF02229883
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02229883